Dyadic International, Inc.
June 16, 2025
Company Presentation
Respiratory
Dyadic International, Inc., founded in 1979, transitioned from an industrial textiles company to a Nasdaq-listed global biotechnology company focused on microbial platforms for biopharmaceutical and bioindustrial production. With decades of biomanufacturing expertise, Dyadic leverages its technology to deliver scalable, cost-effective solutions for global health and industry, partnering with leading companies to develop next-generation proteins and products.
Company HQ City:
Jupiter
Company HQ State:
FL
Company HQ Country:
United States
Year Founded:
1979
Lead Product in Development:
DNAS1
CEO
Mark Emalfarb
Year Founded
1979
Development Phase of Lead Product
NDA Preparation/In Review
Exchange
Nasdaq
Ticker
DYAI
When you expect your next catalyst update?
While we don't have a specific catalyst to announce at this time, we remain focused on executing our long-term strategy. We're advancing key initiatives, building strong partnerships, and leveraging our proprietary technology to create value for stakeholders. As milestones develop, we look forward to keeping you updated.
What is your next catalyst (value inflection) update?
While we don't have a specific catalyst to announce at this time, we remain focused on executing our long-term strategy. We're advancing key initiatives, building strong partnerships, and leveraging our proprietary technology to create value for stakeholders. As milestones develop, we look forward to keeping you updated.
Website
www.dyadic.com
Primary Speaker
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}